Optimizing the CHF6523 Isocoumarin Core Scaffold: From the Preclinical Stage to Large-Scale Production
- 30 June 2025
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (7) , 1809-1821
Abstract
No abstract availableFunding Information
- Ministero delle imprese e del made in Italy (F/130013/00/X38)
This publication has 9 references indexed in Scilit:
- Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary DiseaseJournal of Medicinal Chemistry, 2024
- Recent advances in synthesis of isocoumarins: An overviewTetrahedron, 2023
- Palladium-catalyzed ring-closing reaction of enynols with aminals via methylene transfer and C–N bond activationTetrahedron Chem, 2023
- gem‐Difluoromethylene Alkyne‐Enabled Diverse C−H Functionalization and Application to the on‐DNA Synthesis of Difluorinated IsocoumarinsAngewandte Chemie International Edition, 2020
- Green Chemistry Metrics2015
- Cy2NH·HX-Promoted Cyclizations of o-(Alk-1-ynyl)benzoates and (Z)-Alk-2-en-4-ynoate with Copper Halides to Synthesize Isocoumarins and α-PyroneSynthesis, 2006
- Oligo(octithienylene-diethynylene)s as Unprecedentedly Long Conjugated NanomoleculesOrganic Letters, 2002
- New procedures for the selective synthesis of 2(2H)-pyranone derivatives and 3-aryl-4-iodoisocoumarinsTetrahedron, 2002
- Selective synthesis of natural and unnatural 5,6-disubstituted 2(2H)-pyranones via iodolactonization of 5-substituted (Z)-2-en-4-ynoic acidsTetrahedron, 2001